ImmunTraCkeR testing before and during treatment with ipilimumab in patients with metastatic melanoma

Trial Profile

ImmunTraCkeR testing before and during treatment with ipilimumab in patients with metastatic melanoma

Recruiting
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 Jan 2015

At a glance

  • Drugs Ipilimumab (Primary)
  • Indications Malignant melanoma
  • Focus Biomarker; Pharmacodynamics
  • Acronyms PREDICT-ID
  • Sponsors ImmunID
  • Most Recent Events

    • 16 Dec 2014 New trial record
    • 10 Dec 2014 This study has been authorised by French regulatory bodies and is expected to start in January 2015, according to an ImmunID media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top